Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Federal Home Loan Bank of San Francisco (FHLBank San Francisco) today announced the appointment of Joe Sarci as Senior Vice President and Chief...
-
OAKDALE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Oak Valley Community Bank, a wholly-owned subsidiary of Oak Valley Bancorp (NASDAQ: OVLY), is pleased to welcome Dan Greene as Vice President,...
-
HIAB OYJ, PÖRSSITIEDOTE, 8. JOULUKUUTA 2025 KLO 17.00 Muutoksia Hiabin johtoryhmässä Sanna Ahonen, Johtaja, liiketoiminnan kehittäminen ja vastuullisuus ja Hiabin johtoryhmän jäsen, on päättänyt...
-
HIAB CORPORATION, STOCK EXCHANGE RELEASE, 8 DECEMBER 2025 AT 5:00 PM (EET) Changes in Hiab Leadership Team Sanna Ahonen, EVP, Strategy and Sustainability and member of Hiab Leadership team, has...
-
Delray Beach, FL, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Rising adoption of automated and AI-enabled synthesis platforms positions pharmaceutical and biotechnology companies for accelerated innovationThe...
-
Tel Aviv, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace,...
-
Delray Beach, FL, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The global Transformer Oil Market size is expected to grow from USD 2.0 billion in 2023 to USD 3.0 billion by 2030, at a CAGR of 5.9% according to...
-
American Rare Earths Appoints Mark Wall as Chief Executive Officer to Lead Next Phase of U.S. Growth
DENVER, Dec. 08, 2025 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR”, “American Rare Earths” or the “Company”) is pleased to announce the appointment of Mark...
-
Soleo Health appoints Jody Thompson as SVP of Business Development to expand portfolio of exclusive and limited distribution therapies for rare diseases.
-
Company Urges Shareholders to Follow ISS’ Recommendation and Vote the WHITE Proxy Card BURLINGTON, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or the...